Cognitive Behavioral Therapy for Insomnia and Depression Among Menopausal Women

Sponsor
Beni-Suef University (Other)
Overall Status
Completed
CT.gov ID
NCT05920460
Collaborator
(none)
88
2
2
3.5
44
12.6

Study Details

Study Description

Brief Summary

Considering physical and psychological problems that threaten women during the menopausal period, it seems that therapies that can help women cope with these problems, especially psychological ones, will be useful. The community mental health nurse is usually the first health professional whom women rely on to relieve their menopause symptoms. It is essential for the primary health care nurse to know how to properly approach women at this stage of their life and how to provide them the best and safe treatment. Because only limited interventional studies have been done to manage insomnia and depression among menopausal women in Egypt, the present study focused on reducing and insomnia and depression of menopausal women by using group Cognitive behavioral therapy. The current study aimed to examine the efficiency of group Cognitive Behavioral Therapy for insomnia and depression among menopausal women.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioral Therapy Program
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
88 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Cognitive Behavioral Therapy for Insomnia and Depression Among Menopausal Women: A Randomized Control Trial
Actual Study Start Date :
Jun 15, 2022
Actual Primary Completion Date :
Aug 30, 2022
Actual Study Completion Date :
Sep 29, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental Group

The Cognitive Behavioral Therapy group received seven weekly face-to-face sleep group Cognitive Behavioral Therapy sessions lasting for 50-60 min. The Cognitive Behavioral Therapy program was developed by the research team after reviewing the literature and consulting with experts. Cognitive Behavioral Therapy was held in a lecture hall located in the PPFK branch office before individual counseling was initiated.

Behavioral: Cognitive Behavioral Therapy Program
Brief description of the Cognitive Behavioral Therapy program is given below: Session 1: Mutual understanding and rapprochement Session 2: Sleep hygiene education Session 3: Psychoeducation about stimulus control strategies; monitoring sleep environments, and identification of behavioral habits at bedtime, dysfunctional beliefs, and attitudes about sleep. Session 4: Training on relaxation techniques Session 5: Psycho education about depression Session 6: Cognitive restructuring Session 7: The terminating session

No Intervention: Control Group

The study participants of the control arm were interviewed separately and were given general health advice.

Outcome Measures

Primary Outcome Measures

  1. The effect of Cognitive Behavioral Therapy on Womens' insomnia symptom [8 - 12 weeks]

    the women who received the Cognitive Behavioral Therapy would exhibit a significantly change in insomnia symptom after the program compared to women in the control group. The Insomnia Severity Index (ISI; Morin et al., 2011), the ISI aims to assess the severity of insomnia over the past 2 weeks.

  2. The effect of Cognitive Behavioral Therapy on Womens' depressive levels [8 - 12 weeks]

    the women who received the Cognitive Behavioral Therapy would exhibit a significantly change in depressive levels after the program compared to women in the control group. The Beck Depression Inventory, 2nd edition (BDI-II; Beck et al., 1996), BDI-II aims to assess the depressive symptoms. It is a 21-item self-report statements about how the person had been feeling in the last week. The BDI-II scores range from 0 to 63, with higher scores indicating greater severity.

Secondary Outcome Measures

  1. Correlation between studied variables before application of the intervention [8 - 12 weeks]

    Sleep quality index investigates the correlation significantly to insomnia severity index and beck depression inventory. The Pittsburgh Sleep Quality Index (PSQI) 1989, the PSQI is a self-completed questionnaire that assesses sleep quality over the previous month. The scale has 19-items, five of which should be answered by bed mates or roommates.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women with depression (BDI-II score of 14-63)

  • Women aged between 40 and 55 years old, menopausal (12 consecutive months without menses)

  • Women are willing to provide written informed consent to participate in the study.

  • Women who have the ability to read and write Arabic language.

  • Women who report wake after sleep onset (wakefulness in the middle of the night after falling asleep) of an hour or more on ≥ 3 nights per week and met criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (American Psychiatric Association, 2013) insomnia disorder with onset or exacerbation during the peri- or postmenopausal period per clinical interview with the researcher.

  • Women who have a total score of >5 on the Pittsburgh Sleep Quality Index (PSQI), which indicates poor sleep, and a total score of >7 on the Insomnia Severity Index (ISI), which indicates insomnia.

Exclusion Criteria:
  • Women who are currently under any type of psychotherapy or have a previous experience of Cognitive Behavioral Therapy.

  • Women who have a history of neuropsychiatric illness, cancer, chemotherapy, and sudden stress in the previous 6 months (due to unfortunate events in the family) or have a severe or uncontrolled physical illness.

  • Women who are clearly diagnosed as having sleep disorders or obstructive sleep apnea and had taken sleeping medications.

  • Women who are on hormonal replacement therapy or cancer therapy or drugs such as tricyclic antidepressants, selective serotonin reuptake inhibitors, sedatives, and other hormones; and those who had undergone hysterectomy with oophorectomy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beni-Suef University Banī Suwayf Other Egypt 62511
2 Mansoura University Mansoura Egypt

Sponsors and Collaborators

  • Beni-Suef University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ahmed Loutfy, Ph.D., Lecturer of Nursing, Beni-Suef University
ClinicalTrials.gov Identifier:
NCT05920460
Other Study ID Numbers:
  • Hashem2023
First Posted:
Jun 27, 2023
Last Update Posted:
Jun 27, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 27, 2023